Meta-analysis of folic acid efficacy trials in stroke prevention

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Neurology

• Publication date

  2017-05-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.1212/WNL.0000000000003909PMID 28404799
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Elevated Homocysteine Concentrations Decrease the Antihypertensive Effect of Angiotensin-Converting Enzyme Inhibitors in Hypertensive Patients

  2017cited by this paper
• Metabolic vitamin B12 deficiency: a missed opportunity to prevent dementia and stroke.

  2016cited by this paper
• Folic Acid Supplementation and the Risk of Cardiovascular Diseases: A Meta‐Analysis of Randomized Controlled Trials

  2016cited by this paper
• Excessive folic acid intake and relation to adverse health outcome.

  2016cited by this paper
• Effects of 2-year vitamin B12 and folic acid supplementation in hyperhomocysteinemic elderly on arterial stiffness and cardiovascular outcomes within the B-PROOF trial

  2015cited by this paper
• Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial.

  2015cited by this paper
• Oral High-Dose Multivitamins and Minerals After Myocardial Infarction

  2013cited by this paper
• Rapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010

  2013cited by this paper
• Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.

  2012cited by this paper
• EFFICACY OF FOLIC ACID SUPPLEMENTATION IN STROKE PREVENTION: NEW INSIGHT FROM A META-ANALYSIS

  2012cited by this paper
• Homocysteine-Lowering and Cardiovascular Disease Outcomes in Kidney Transplant Recipients: Primary Results From the Folic Acid for Vascular Outcome Reduction in Transplantation Trial

  2011cited by this paper
• Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial.

  2010cited by this paper
• B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial.

  2010cited by this paper
• B Vitamins and the Risk of Total Mortality and Cardiovascular Disease in End-Stage Renal Disease: Results of a Randomized Controlled Trial

  2010cited by this paper
• Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial

  2010cited by this paper
• Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial.

  2010cited by this paper
• Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement

  2009cited by this paper
• Folic Acid-Based Intervention in Non-ST Elevation Acute Coronary Syndromes

  2009cited by this paper
• Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH)

  2009cited by this paper
• Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial.

  2008cited by this paper
• Angiography : A Randomized Controlled Trial CoronaryWith Homocysteine-Lowering B Vitamins After Mortality and Cardiovascular Events in Patients Treated

  2008cited by this paper
• Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease

  2007cited by this paper
• Uremic hyperhomocysteinemia: A randomized trial of folate treatment for the prevention of cardiovascular events

  2007cited by this paper
• Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial.

  2007cited by this paper
• Efficacy of folic acid supplementation in stroke prevention: a meta-analysis.

  2007cited by this paper
• Folic acid for the prevention of colorectal adenomas: a randomized clinical trial.

  2007cited by this paper
• Homocysteine-lowering vitamin B treatment decreases cardiovascular events in hemodialysis patients

  2007cited by this paper
• Homocysteine lowering and cardiovascular events after acute myocardial infarction.

  2006cited by this paper
• Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial.

  2006cited by this paper
• Homocysteine-Lowering Vitamin B Treatment Decreases Cardiovascular Events in Hemodialysis Patients

  2006cited by this paper
• Secondary prevention with folic acid: results of the Goes extension study

  2005cited by this paper
• Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials.

  2005cited by this paper
• Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: A randomized, placebo-controlled, double-blind trial.

  2004cited by this paper
• Efficacy of folic acid when added to statin therapy in patients with hypercholesterolemia following acute myocardial infarction: a randomised pilot trial.

  2004cited by this paper
• Folate therapy and in-stent restenosis after coronary stenting.

  2004cited by this paper
• Randomized trial of folic acid for prevention of cardiovascular events in end-stage renal disease.

  2004cited by this paper
• Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial.

  2004cited by this paper
• Secondary prevention with folic acid: effects on clinical outcomes.

  2003cited by this paper
• Effects of folic acid treatment on homocysteine levels and vascular disease in hemodialysis patients.

  2003cited by this paper
• Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial.

  2002cited by this paper
• Lowered risks of hypertension and cerebrovascular disease after vitamin/mineral supplementation: the Linxian Nutrition Intervention Trial.

  1996cited by this paper

• Complex Effects of B-Vitamin Combinations on Cardiovascular Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials over Three Decades

  2026cites this paper
• Nutrition and brain health: Implications of Mediterranean diet elements for psychiatric disorders.

  2025cites this paper
• Posttreatment Blood Pressure as a Key Predictor in a 5‐Year Stroke Prediction Model

  2025cites this paper
• Folic acid for the primary prevention of stroke: a systematic review and meta-analysis

  2024cites this paper
• Folic acid supplementation for stroke prevention: A systematic review and meta-analysis of 21 randomized clinical trials worldwide.

  2024cites this paper
• Untangling the uncertainty in B vitamins for stroke prevention: folic acid fortification, dosage, and their interaction?

  2024cites this paper
• Dosage exploration of combined B-vitamin supplementation in stroke prevention: a meta-analysis and systematic review.

  2024cites this paper
• Reply-letter to the editor: Comment on: "Folic acid supplementation for stroke prevention: A systematic review and meta-analysis of 21 randomized clinical trials worldwide".

  2024cites this paper
• The Multitarget Action of Vitamins in the Ischemic Stroke.

  2024cites this paper
• Systemic immune-inflammation index predicts first stroke and affects the efficacy of folic acid in stroke prevention

  2024cites this paper
• Prevalence and predictors of low folate levels among stroke survivors in a country without mandatory folate food fortification: Analysis of a Ghanaian sample.

  2023cites this paper
• Precision nutrition: 8 stages and 5 dimensions

  2023cites this paper
• Role of Vitamins in Cardiovascular Health: Know Your Facts - Part 1.

  2023cites this paper
• Do B Vitamins Enhance the Effect of Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Diseases? A Systematic Review of Clinical Trials

  2022cites this paper
• Relationship of several serum folate forms with the risk of mortality: A prospective cohort study.

  2021cites this paper
• Urinary albumin-to-creatinine ratio and the risk of first stroke in Chinese hypertensive patients treated with angiotensin-converting enzyme inhibitors

  2021cites this paper
• The Role of Supplementation with Natural Compounds in Post-Stroke Patients

  2021cites this paper
• Neutrophil counts and the risk of first stroke in general hypertensive adults

  2021cites this paper
• Interaction of serum calcium and folic acid treatment on first stroke in hypertensive males.

  2020cites this paper
• Interaction of serum vitamin B12 and folate with MTHFR genotypes on risk of ischemic stroke

  2020cites this paper
• Dietary Intake of Homocysteine Metabolism-Related B-Vitamins and the Risk of Stroke: A Dose-Response Meta-Analysis of Prospective Studies

  2020cites this paper
• Endothelial Dysfunction May Link Interatrial Septal Abnormalities and MTHFR-Inherited Defects to Cryptogenic Stroke Predisposition

  2020cites this paper
• Insufficiency of B vitamins with its possible clinical implications

  2020cites this paper
• Serum alkaline phosphatase levels and the risk of new-onset diabetes in hypertensive adults

  2020cites this paper
• Association Between Folate and Health Outcomes: An Umbrella Review of Meta-Analyses

  2020cites this paper
• Interaction of neutrophil counts and folic acid treatment on new-onset proteinuria in hypertensive patients

  2020cites this paper
• The role of diet in secondary stroke prevention.

  2020cites this paper
• Estimated Stroke-Free Survival of Folic Acid Therapy for Hypertensive Adults

  2019cites this paper
• The effect of folic acid in patients with cardiovascular disease

  2019cites this paper
• 2018 Chinese Guidelines for Prevention and Treatment of Hypertension—A report of the Revision Committee of Chinese Guidelines for Prevention and Treatment of Hypertension

  2019cites this paper
• Epigenetic regulation of inflammation in stroke

  2018cites this paper
• ARSENIC, TARGETED METABOLOMICS AND DIABETES-RELATED OUTCOMES: CONNECTING THE DOTS IN THE STRONG HEART STUDY

  2018cites this paper
• The health benefits and risks of folic acid fortification of food

  2018cites this paper
• Association between serum total homocysteine and arterial stiffness in adults: a community‐based study

  2018cites this paper
• Effect of long-term low-dose folic acid supplementation on degree of total homocysteine-lowering: major effect modifiers

  2018influential citation
• The modifying effect of the MTHFR genotype on the association between folic acid supplementation and pulse wave velocity: Findings from the CSPPT

  2018cites this paper
• Arsenic, one carbon metabolism and diabetes-related outcomes in the Strong Heart Family Study.

  2018cites this paper
• B vitamins for stroke prevention

  2018cites this paper
• The current status of homocysteine as a risk factor for cardiovascular disease: a mini review

  2018cites this paper
• Reply to J Dierkes et al.

  2018cites this paper
• Dietary Approaches for Stroke Prevention

  2017cites this paper
• Effect of MTHFR A 1298 C and MTRR A 66 G genetic mutations on homocysteine levels in the Chinese population : a systematic review and meta-analysis

  2017cites this paper
• Association between percent decline in serum total homocysteine and risk of first stroke

  2017cites this paper
• Effect of MTHFR A1298C and MTRR A66G genetic mutations on homocysteine levels in the Chinese population: a systematic review and meta-analysis

  2017cites this paper
• The Role of Nutrition in the Risk and Burden of Stroke: An Update of the Evidence

  2017cites this paper
• H -type Hypertension 2.0 — Development of Drugs Targeting the Precision Prevention of Stroke

  year unknowncites this paper